GGrantIndex
Sort

326,823 grants matching clinical trial

GHESKIO Clinical Trials Unit

$1,835,823
Jean William Pape · Gheskio Center · UM1 · FY2021 · AI

Stellenbosch University Clinical Trial Unit, Cape Town, South Africa

$1,835,675
Mark Fredric Cotton · Stellenbosch University · U01 · FY2010 · AI

Molecular Biology Of Outer Retina-specific Proteins

$1,835,577
Thomas Redmond · National Eye Institute · ZIA · FY2011 · EY

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$1,835,382
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

KIDNEY DISEASE/HYPERTENSION IN AFRICAN AMERICANS--DCC

$1,835,274
Cleveland Clinic Foundation · U01 · FY2000 · DK

University of Cincinnati AIDS Clinical Trials Unit- UC ACTU

$1,835,084
Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2010 · AI

Molecular Analysis Of Human Hereditary Deafness

$1,834,765
Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC

COLORADO ADULT AIDS CLINICAL TRIALS UNIT

$1,834,346
University Of Colorado Denver · U01 · FY2000 · AI

Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)

$1,834,272
Holden T. Maecker · Stanford University · U24 · FY2025 · CA

Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)

$1,834,272
Holden T. Maecker · Stanford University · U24 · FY2024 · CA

TEXAS CANCER GENETICS CONSORTIUM

$1,833,963
University Of Texas Md Anderson Can Ctr · U24 · FY2002 · CA

Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa

$1,833,933
Diane V Havlir · University Of California, San Francisco · P01 · FY2013 · HD

Design Of Immunogens

$1,833,636
Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Clinical Trials Network, Ohio Valley Node

$1,833,565
Eugene C. Somoza · University Of Cincinnati · U10 · FY2006 · DA

HIV VACCINES TRIAL UNITS

$1,833,511
Fred Hutchinson Cancer Research Center · U01 · FY2000 · AI

Neuroimaging Acupuncture Effects Brain Activity in Chronic low Back Pain

$1,833,493
Bruce R Rosen · Massachusetts General Hospital · P01 · FY2013 · AT

Health Promotion Research Center

$1,833,421
Jeffrey Randall Harris · University Of Washington · U48 · FY2013 · DP

IND-enabling studies for a potent and efficient neuroprotective drug

$1,833,347
Robyn L Goforth · Neurexis Therapeutics, Inc. · R44 · FY2025 · NS

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,833,254
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease

$1,833,218
Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG

Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease

$1,833,217
Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG

PREVENTION OF CARDIOVASCULAR DISEASE IN DIABETES MELLITU

$1,833,206
Case Western Reserve University · N01 · FY2000 · HC

A-Z Clinical Trials Unit

$1,833,108
Edgar T Overton · University Of Alabama At Birmingham · UM1 · FY2021 · AI

Administrative Core

$1,832,612
Rima F Kaddurah-Daouk · Duke University · U19 · FY2020 · AG

Alterations In Lipid Metabolism In The Nervous System By Ethanol

$1,832,592
Hee-Yong Kim · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA